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Abstract
Background: Cellular senescence is a state reached by normal mammalian cells after a finite number of
cell divisions and is characterized by morphological and physiological changes including terminal cell-cycle
arrest. The limits on cell division imposed by senescence may play an important role in both organismal
aging and in preventing tumorigenesis. Cellular senescence and organismal aging are both accompanied by
increased DNA damage, seen as the formation of γ-H2AX foci (γ-foci), which may be found on uncapped
telomeres or at non-telomeric sites of DNA damage. However, the relative importance of telomere- and
non-telomere-associated DNA damage to inducing senescence has never been demonstrated. Here we
present a new approach to determine accurately the chromosomal location of γ-foci and quantify the
number of telomeric versus non-telomeric γ-foci associated with senescence in both human and mouse
cells. This approach enables researchers to obtain accurate values and to avoid various possible
misestimates inherent in earlier methods.
Results:  Using combined immunofluorescence and telomere fluorescence in situ hybridization on
metaphase chromosomes, we show that human cellular senescence is not solely determined by telomeric
DNA damage. In addition, mouse cellular senescence is not solely determined by non-telomeric DNA
damage. By comparing cells from different generations of telomerase-null mice with human cells, we show
that cells from late generation telomerase-null mice, which have substantially short telomeres, contain
mostly telomeric γ-foci. Most notably, we report that, as human and mouse cells approach senescence, all
cells exhibit similar numbers of total γ-foci per cell, irrespective of chromosomal locations.
Conclusion:  Our results suggest that the chromosome location of senescence-related  γ-foci is
determined by the telomere length rather than species differences per se. In addition, our data indicate
that both telomeric and non-telomeric DNA damage responses play equivalent roles in signaling the
initiation of cellular senescence and organismal aging. These data have important implications in the study
of mechanisms to induce or delay cellular senescence in different species.
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Background
Normal mammalian cells have a finite replicative
lifespan. After a certain number of cell divisions in vitro,
these cells undergo a process known as cellular senes-
cence, which is characterized by an irreversible cell-cycle
arrest accompanied by other physiological and morpho-
logical changes [1,2]. Cellular senescence is important for
preventing tumorigenesis in vivo and in addition may play
a role in organismal aging [3,4]. There is considerable evi-
dence suggesting that accumulation of DNA damage plays
a critical role in both in vitro senescence and in vivo aging
[5-9].
One category of senescence-associated DNA damage that
has received a great deal of attention is the damage
response associated with telomere shortening and conse-
quent telomere dysfunction or uncapping [10]. It has
been shown that DNA repair proteins, including γ-H2AX
[11,12], are localized at uncapped telomeres [13]. This tel-
omeric DNA damage response has also been shown to be
a potential inducer of senescence or cell death [5-7], as
well as of in vivo aging in both model systems and human
pathology [3]. Therefore, it has been proposed that repli-
cative cellular senescence is induced by telomere dysfunc-
tion [5-7,14].
However, there is considerable evidence that cellular
senescence and organismal aging can occur through
mechanisms other than telomere dysfunction [15-17]. For
example, cells of laboratory mice, which have long telom-
eres, reach senescence in culture without apparent tel-
omere uncapping [18]. The time necessary to reach
senescence is increased when the cultures are maintained
in a reduced (3%) oxygen atmosphere, suggesting that
oxidative stress is involved [19].
Total numbers of DNA damage foci were found to
increase similarly in both human and mouse cells during
in vivo aging and during in vitro culture-induced cellular
senescence [8,9]. Given the previous observation that tel-
omeric foci are substantially more frequent in human
than in mouse cells, these findings suggest that the overall
DNA damage foci observed with aging and senescence
may also include those with telomere-independent ori-
gins. Therefore, a complete understanding of the factors
affecting senescence and aging requires knowledge of the
relative contributions of telomeric and non-telomeric
DNA damage.
In order to understand the relationship between these two
types of DNA damage and in vivo and in vitro aging, we
applied a technique that directly reveals the position of γ-
foci on chromatids in metaphase spreads of human and
mouse cells and simultaneously assesses the condition of
the telomeres through telomere-fluorescence in situ
hybridization (FISH) [20]. This technique permits locali-
zation of γ-foci to either the chromatid arms, correspond-
ing to non-telomeric DNA damage, or to the end of the
chromatid, corresponding to telomere damage. Telomere-
FISH carried out in parallel provides a useful indication of
the status of telomere shortening of these chromatids.
Using this technique, we confirm our previous findings
that DNA damage accumulates similarly in both human
and mouse cells during the replicative lifespan [8] and
that the total number of γ-foci appeared to be a consistent
characteristic of the senescent state. In addition, by com-
paring cells from different generations of telomerase-null
mice, we show that telomere length, rather than other dif-
ferences between human and mouse, determines the dif-
ferential pattern of senescence-associated DNA damage.
This study demonstrates that the mechanism(s) of senes-
cence-associated DNA damage involve both telomere-
and non-telomere-associated foci, with the distribution of
these two components dependent, to a large degree, upon
the length and presumably, the functionality of the telom-
eres.
Results
Human and mouse primary cells show different patterns of 
senescence-related γ-foci
Metaphase chromosome spreads were prepared from cul-
tures of human and mouse cells at low population dou-
bling (PD) times and during the penultimate PD before
the onset of senescence (hereafter termed pre-senescent)
(experimental details are described in Additional file 1).
Senescence status was defined by both growth arrest and
senescence-associated β-galactosidase (SA-β-gal) staining
assay (> 90% SA-β-gal positive cells in human cultures,
and > 80% SA-β-gal positive cells in mouse cultures)
(Additional files 2A and 2B). Metaphase chromosomes
were stained for γ-H2AX and for telomeric DNA in order
to measure the numbers of uncapped telomeres and other
types of DNA double-strand breaks (DSBs) (Figure 1A and
1B) [20]. Telomere-FISH/γ-H2AX staining of metaphase
spreads permits visualization of the precise location of γ-
foci on the chromosomes and their classification (Figure
1B), including those at the chromosomal ends lacking
detectable telomere repeats (Figure 1B, FISH negative).
The colcemid treatment did not affect γ-foci formation
(Additional file 2C).
Cultures of two proliferating normal human fibroblast
strains, lung WI-38 and skin BJ, exhibited increasing num-
bers of total γ-foci over time (Figure 2A and 2B, black
bars). The technique revealed that at low PDs, the num-
bers of non-telomeric foci were greater than or equal to
the numbers of telomeric foci, however, after increasing
PDs and cumulative cell divisions, the foci were primarily
telomeric, accounting for about 70% of the total number
of foci in pre-senescent cultures (Figure 2A and 2B, blueEpigenetics & Chromatin 2008, 1:6 http://www.epigeneticsandchromatin.com/content/1/1/6
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bars). Among the total γ-foci at the chromatid ends in pre-
senescent WI-38 and BJ cells, most of the γ-foci were neg-
ative for FISH signal (Figure 2C and 2D, dark blue bars),
suggesting that these γ-foci were at critically short, dys-
functional telomeres. Interestingly, pre-senescent WI-38
cells contain fewer telomeric foci and more non-telomeric
foci than do BJ cells. These results suggest that the WI-38
lung fibroblasts may be more susceptible to non-telom-
e r i c  D N A  d a m a g e  i n  a g r e e m e n t  w i t h  p r e v i o u s  s t u d i e s
based on stress-related protein induction [21]. These
results indicate that reliance on telomere-FISH or tel-
omere-associated proteins in interphase cells to determine
γ-focal positioning potentially underestimates the num-
bers of telomeric γ-foci [8,14,22,23]. These results confirm
that during senescence in human cells, telomeric DNA
damage increases while the non-telomeric DNA damage is
already present in low PD cultures and appears to be a
characteristic of the specific cell line. Our recently pub-
lished analysis comparing γ-focal distribution in met-
aphases of young and senescent primary fibroblasts from
a normal and a Werner syndrome (WS) donor showed a
similar pattern of increased telomere-associated γ-foci
during cellular senescence and in WS cultures [9]. This
confirms that increasing telomere dysfunction plays a pri-
mary role in producing senescence- and age-associated
DNA damage in humans.
Mouse embryonic fibroblast (MEF) cultures also exhib-
ited increasing total numbers of γ-foci as they proliferated
(Figure 3A, 20% O2, black bars). In low PD MEFs, non-tel-
omeric foci outnumbered telomeric foci similar to human
cells. However, at high PDs, the increased foci were prima-
rily non-telomeric, accounting for approximately 80% of
the total focal numbers in pre-senescent cultures (Figure
3A, 20% O2, gray bars). It has been shown that normoxic
conditions are stressful to MEF growth, leading to earlier
senescence, which can be lessened by growth in 3% O2
[16,19]. When pre-senescent MEFs growing in normoxic
conditions were transferred to a 3% O2 atmosphere at
seven PDs and cultured to the penultimate PD (experi-
mental details are described in Additional file 1), the
number of γ-foci along the chromatid arms significantly
decreased (Figure 3A, 3% O2, gray bar), supporting the
notion that a sizeable fraction of non-telomeric foci were
caused by oxidative stress and that this stress plays a pri-
mary role in cellular senescence in mouse cells. MEFs
growing in 3% O2 exhibited increased numbers of γ-foci
on chromosome ends (Figure 3A, 3% O2, blue bar). This
result suggested that these telomeres are dysfunctional, a
surprising result for mouse cells. However, this notion
was confirmed by the result that over 66% of these telom-
eric γ-foci were FISH negative (Figure 3B, dark blue bars),
independent evidence from the γ-foci that these telomeres
may be dysfunctional. Growth in 3% O2 permits addi-
tional cell replication (experimental details are described
in Additional file 1) with accompanying telomere short-
ening, suggesting that shortened telomeres might accu-
mulate during this time. The effects of culturing at low
oxygen on MEF proliferation and on the number of DNA
damage were monitored daily after transfer (Figure 3C
and 3D), (experimental details are described in Addi-
tional file 3). When MEFs at three PDs were transferred
from 20% O2 to 3% O2, cell growth accelerated (Figure
3C) and the total number of γ-foci decreased. In contrast,
γ-H2AX immunostaining on metaphase chromosomes Figure 1
γ-H2AX immunostaining on metaphase chromosomes. (A) Typical metaphase spreads of human (left) and mouse 
(right) fibroblasts stained for γ-H2AX (green) and telomeric DNA (red). (B) Scoring of foci as along the chromatid arms, prox-
imal or distal to the telomeres, or on the chromatid ends, fluorescence in situ hybridization negative or positive.Epigenetics & Chromatin 2008, 1:6 http://www.epigeneticsandchromatin.com/content/1/1/6
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Distribution of senescence-related γ-foci in human fibroblasts Figure 2
Distribution of senescence-related γ-foci in human fibroblasts. (A-B) Distribution of γ-foci on the metaphases of low 
and high population doublings (PDs) (pre-senescent), human embryo lung fibroblast (WI-38) (A) and foreskin fibroblast (BJ) (B). 
Proportion (%) of each type of damage is shown in each graph bar. Scoring is as in Figure 1B. (C-D) Scoring of the γ-foci as 
along the chromatid arms proximal to the telomere, along the chromatid arms distal to the telomeres, on the chromatid ends 
with fluorescence in situ hybridization (FISH) signal or on the chromatid ends without FISH signal. Low and high PDs of WI-38 
cells (C) and BJ cells (D). On average more than 10 metaphases were screened per point in independent experiments. Error 
bars signify standard errors.
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MEFs transferred from 3% to 20% exhibited increased
numbers of γ-foci (Figure 3D). These findings again sug-
gest that a sizeable fraction of DNA damage was caused by
oxidative stress.
To examine the nature of the γ-foci on the chromosome
arms and chromatid ends more directly, we introduced
telomere reverse transcriptase (TERT) in pre-senescent WI-
38 cell populations. TERT expression led to an elongation
of telomeres (data not shown) and to a decrease in the
proportion of γ-foci on the chromatid ends in the human
WI-38 cells, consistent with the idea that γ-foci localized
to uncapped telomeres (Figure 4A, Ends, compare high
PDs with TERT). In contrast to human cells, spontane-
ously immortalized mouse cells [24] displayed no change
in the already small proportion of γ-foci at telomeres (Fig-
ure 4B, Ends, compare high PDs with immortalized MEF
(IM)). These results support the hypothesis that most if
Distribution of senescence-related γ-foci in mouse embryo fibroblasts Figure 3
Distribution of senescence-related γ-foci in mouse embryo fibroblasts. (A) Distribution of γ-foci on metaphases of 
primary mouse embryonic fibroblasts (MEF), low population doublings (PDs), high PDs in 20% O2 and 3% O2 (see Additional 
file 1 for experimental details). Proportion (%) of each type of damage is shown in each graph bar. Scoring is as in Figure 1B. (B) 
Scoring of γ-foci as along the chromatid arms proximal to telomere, along the chromatid arms distal to the telomeres, on the 
chromatid ends with fluorescence in situ hybridization (FISH) signal or on the chromatid ends without FISH signal. On average 
more than 10 metaphases were screened per point in independent experiments. (C) MEFs cultured in 20% O2 (triangle) were 
shifted at day 5 to 3% O2 (square), or maintained in 20% O2. The average of two cultures is shown. Note that the cultures 
transferred from 20% to 3% O2 in panel A were already pre-senescent, and also became senescent in 3% O2. The cultures 
transferred from 20% to 3% O2 in this panel were low PDs and accelerated growth in 3% O2. (D) Number of γ-foci in MEFs 
after oxygen transfer is shown. See Additional file 3 for experimental details. Error bars signify standard errors.
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not all γ-foci on the chromosome ends are due to telomere
dysfunction.
Telomere length can be maintained in the absence of tel-
omerase by a process termed alternative lengthening of
telomeres (ALT) [25]. When VA-13 cells, a SV40-trans-
formed variant of WI-38, which exhibits the ALT pheno-
type, were examined, the proportion of γ-foci on the
chromatid ends was similar to that of pre-senescent WI-38
and higher than that of TERT-transduced WI-38 (Figure
4A, Ends, compare high PDs, TERT and ALT). Interest-
ingly, about half of the γ-foci on the chromatid ends in
VA-13 cells were FISH positive (see Additional file 4), sug-
gesting that in these human cells, telomeres maintained
by ALT are recognized as DNA damage even if sufficiently
long to be scored as FISH positive.
In the second procedure, we added the antioxidant tem-
pol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl),
known to increase the lifespan of mice [26,27], to cell cul-
tures nearing senescence (experimental details are
described in Additional file 1). There was a substantial
decrease in the total number of γ-foci in mouse cell cul-
tures grown for 48 hours in medium including tempol
(Figure 4B, Total, compare high PDs at normal conditions
(high PDs) with antioxidant tempol (OX)). This decrease
in the total number of γ-foci was caused by a significant
decrease in the fraction of non-telomeric foci (Figure 4B,
Arms, compare high PDs with OX). In addition, SA-β-gal
positive cells decreased after the tempol treatment (see
Additional file 2B). In human cell cultures, the presence of
tempol also led to decreased numbers of non-telomeric γ-
foci (Figure 4A, Arms, compare high PDs with OX) and to
slight decreased number of SA-β-gal positive cells (see
Additional file 2A). These results indicate that a sizeable
fraction of γ-foci on the chromatid arms are of oxidative
origin. In contrast, the presence of tempol did not affect
the numbers of telomeric γ-foci in either human or mouse
cell cultures (Figure 4A and 4B, Ends, compare high PDs
with OX).
Different telomere lengths in telomerase-null mouse cells 
lead to different patterns of γ-foci
To determine whether the observed differences between
patterns of γ-foci in human versus mouse cells might be
due solely to differences in telomere length or whether
other differences are involved, we utilized cells from mice
lacking either the gene for mTERT or the gene for mouse
telomerase RNA template (mTR). In these mice, each suc-
cessive generation contains shorter telomeres until phe-
notypic effects of uncapped telomeres similar to those
found in human cells appear in the fourth (G4) or fifth
(G5) generation [28,29]. Comparison of γ-foci patterns
between early generation mice and late generation mice
can address the contribution of different length of telom-
eres to the distribution of γ-foci in the same species. MEFs
were generated from second (G2) and fifth (G5) genera-
tion TERT-null mice grown to senescence. In metaphase
spreads from pre-senescent G2 mouse cells, 66% of the γ-
foci were on the chromatid arms and 34% were on the
ends (Figure 5A, TEG2, high PDs), a senescence-related γ-
focus distribution pattern similar to that observed in wild-
type MEFs (Figure 3A, 20% O2, high PDs). In contrast, in
metaphase spreads from pre-senescent G5 MEFs, 35% of
the γ-foci were on the chromatid arms and 65% on the
ends (Figure 5A, TEG5, high PDs), a pattern similar to that
found in normal human cells (Figure 2A and 2B, high
PDs).
An important biological question concerns the relation-
ship between in vitro senescence and in vivo aging. We
therefore analyzed young and old G1 and G5 mTR-null
Origins of senescence-associated γ-foci Figure 4
Origins of senescence-associated γ-foci. (A) Distribu-
tion of γ-foci in high population doubling (PD) WI-38 cells, 
after the expression of telomerase (TERT), after culturing 
with the 50 μM antioxidant tempol (OX), or in VA-13 with 
alternative lengthening of telomeres (ALT). (B) Distribution 
of γ-foci in high PD mouse embryonic fibroblast (MEF) cells, 
in spontaneously immortalized MEF cells (IM) or after cultur-
ing with the 50 μM tempol (OX). Scoring is as in Figure 1B. 
On average more than 10 metaphases were screened per 
point in independent experiments. Error bars signify standard 
errors.
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Effect of telomerase deficiency on the distribution of senescence-related γ-foci and activation of damage signaling Figure 5
Effect of telomerase deficiency on the distribution of senescence-related γ-foci and activation of damage signal-
ing. (A) Distribution of γ-foci in low population doubling (PD) and pre-senescent mouse embryonic fibroblasts (MEFs) from 
second (TEG2) and fifth (TEG5) generation telomere reverse transcriptase (TERT)-null mice. (B) Distribution of γ-foci in 
splenic lymphocytes taken from young and old first (TRG1) generation mTR-null mice, and from young and old fifth (TRG5) 
generation mTR-null mice. Scoring is as in Figure 1B. On average more than 10 metaphases were screened per point in inde-
pendent experiments. Error bars signify standard errors. (C) Levels of DNA damage checkpoint proteins in early and high PDs 
MEFs from second (TEG2) and fifth (TEG5) generation TERT-null mice. Relative induction in senescent compared with low PD 
cells of the proteins shown in the left panel. Dashed line denotes no induction.Epigenetics & Chromatin 2008, 1:6 http://www.epigeneticsandchromatin.com/content/1/1/6
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mice, in order to compare the effect of in vivo aging of
splenic lymphocytes with that of in vitro MEF senescence
discussed above. Splenic lymphocytes were obtained from
these mice, stimulated to enter the cell cycle, and har-
vested at mitosis for metaphase spreads. Results obtained
were similar to those obtained with MEFs that had under-
gone senescence in vitro (Figure 5B, compare with 5A).
The increase in total γ-foci in old compared with young
mTR-null mice (Figure 5B, black bars) was similar to that
between early and high PDs MEFs from TERT-null mice
(Figure 5A, black bars). In addition, the distribution of
foci between the chromatid arms and ends was affected by
aging in a manner similar to the observed effect of long-
term culturing of MEFs (Figure 5A and 5B, gray and blue
bars). In lymphocytes from old G1 mTR-null mice, 69%
of the γ-foci were found on the chromatid arms (Figure
5B, TRG1, Old), similar to the 66% found in pre-senes-
cent G2 TERT-null MEFs (Figure 5A, TEG2, high PDs) and
pre-senescent wild-type MEFs (Figure 3A, 20% O2, high
PDs). In contrast, in lymphocytes from old G5 mTR-null
mice, only 37% of the γ-foci were found on the chromatid
arms (Figure 5B, TRG5, Old), similar to the fractions
found for the pre-senescent G5 TERT-null MEFs (Figure
5A, TEG5, high PDs) and the human cells (Figure 2A and
2B, high PDs), where the majority of γ-foci were at the
chromatid ends. When telomere lengths were measured
in wild-type and different generations of TERT-null mice,
they were found to decrease with each generation and to
be inversely proportional to the fraction of γ-foci on the
chromatid ends (data not shown) [29]. These findings
indicate that the different patterns of γ-focus distribution
are due primarily to telomere length and not other mouse-
human species differences. Importantly, these findings
indicate that a similar distribution of γ-foci occurs in
mouse cells during in vitro senescence as well as with in
vivo aging.
The senescence-related, DNA-damage response involves
two pathways, p21–p53 and p16-Rb. It has been sug-
gested that the p21–p53 pathway is the main trigger for
telomere-related senescence, while the p16-Rb pathway
initiates stress-induced senescence [2,21,30]. To investi-
gate differences in the activation of these damage signal-
ing pathways in G2 and G5 TERT-null MEFs, we measured
the induction of several key DNA damage and cell cycle
checkpoint proteins (Figure 5C). Interestingly, p53, p21
and p16 levels were all spontaneously higher in G5 TERT-
null MEF cells than in G2 cells (Figure 5C, compare TEG2
low with TEG5 low), suggesting that cumulative genera-
tions of breeding activate the checkpoint pathways in tel-
omerase-deficient mice. However, serine-15
phosphorylation of p53 was extensive in TERT-null senes-
cent MEFs from G5 mice but not in those from G2 mice
(Figure 5C, p53 S15 PO4). These results substantiate that
the p53 pathway, which is important in telomere-related
cellular senescence in human cells [7,21], is also activated
in senescent MEFs from late generation TERT-null mice. In
contrast, p16 was induced in senescent G2 but not G5
cells (Figure 5C, p16), suggesting that p16 may be less
important in telomere-related senescence [31]. p21 levels
increased in both the G5 and G2 senescent MEFs (Figure
5C, p21), suggesting that p21 could be induced by both
telomeric and non-telomeric DNA damage signals in
mouse cells [32]. These findings suggest that, in addition
to differences in patterns of γ-focus distribution between
early and late-generation telomerase-null mice, DNA
damage pathways leading to cellular senescence also dif-
fer primarily as a consequence of different telomere
lengths.
Senescent mammalian cells contain a similar number of γ-
foci irrespective of origin
In this study, we analyzed the localization of γ-foci in cell
populations including those undergoing in vitro senes-
cence and those undergoing in vivo aging. All the cell pop-
ulations in the penultimate PDs in vitro or from in vivo
aged mice, exhibited similar numbers of total γ-foci, even
though the distribution of γ-foci on the chromatid ends
and arms differed widely (Figure 6A). The total average
numbers of γ-foci fall in a window of 8 to 11 γ-foci per
metaphase, grouping around a mean of 9.5 (Figure 6B)
and with a distribution similar to a Poisson distribution
calculated on that mean, suggesting that the process may
be partially stochastic. Thus we propose that senescence in
mammalian cells in vivo and in vitro is associated with a set
number of DNA lesions identified as γ-foci in a cell popu-
lation and that the number, rather than the origin, of the
lesions is the important determinant of senescence.
Discussion
Since Hayflick and Moorhead [1] reported that normal
human cells in culture are limited in replicative capacity
to a finite number of PDs, efforts have been made to elu-
cidate the mechanism behind this process and to relate it
to organismal aging. That DNA damage plays an impor-
tant role in aging is evidenced by the finding that prema-
ture aging syndromes, such as WS, ataxia telangiectasia,
and Bloom syndrome, are defective in DNA DSB repair
[3]. Recently we demonstrated that delayed accumulation
of DNA DSB repair foci has been detected in primary cells
from aged donors and WS donors as well as in senescent
cells in culture [9]. These findings suggest that altered
DNA DSB damage responses are a common characteristic
in cellular and organismal aging. In fact, many studies
have shown that DNA DSBs marked by γ-foci accumulate
during in vivo aging and in vitro senescence [5-9,14]. These
studies also suggested that senescence can be induced by
the accumulation of DNA damage. Telomere shortening,
which occurs during cell replication, is one of the factors
that contribute to senescence- and age-associated DNAEpigenetics & Chromatin 2008, 1:6 http://www.epigeneticsandchromatin.com/content/1/1/6
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damage in humans. Telomeres that are critically short
become functionally 'uncapped' and exhibit DNA damage
γ-foci [13]. However, telomere shortening is not a major
factor in the senescence of normal mouse cells whose tel-
omeres are sufficiently long to avoid uncapping [18]. It
has been shown that non-telomeric DNA damage initi-
ated by environmental stresses such as atmospheric oxy-
gen can be important senescence inducers in mouse cells
[19]. Thus, it appears that an accumulation of different
types of DNA damage lead to senescence in human and
mouse cells. Although it has been suggested that different
mechanisms of senescence may operate in human and
mouse cells, the relative contributions of these two types
of DNA damage have never been quantified. Previous
studies have utilized techniques that fail to measure accu-
rately the relative contributions of telomere-associated
and non-telomere-associated DNA damage in cellular and
organismal aging. A number of studies have relied upon
double-staining of interphase cells for γ-H2AX and telom-
eric DNA sequences or the telomere-associated protein
TRF2 [8,14,22,23]. However, while these studies demon-
strated the presence of γ-foci on telomeres in interphase
cells, the numbers were underestimated because γ-foci on
telomeres too short to be visualized by staining for telom-
eric DNA or TRF2 were scored as non-telomeric. In fact,
the present study revealed that most of the γ-foci at the
chromatid ends in pre-senescent human cells were tel-
omere-FISH negative (Figure 2C and 2D). Therefore, the
efficiency of detecting telomeric repeats might be different
depending on cell type (interphase versus metaphase) and
previous studies might have underestimated the associa-
tion of γ-foci with extremely short telomeres lacking telo-
meric-FISH signals or TRF2 foci. In addition, while
chromatin immunoprecipitation/micro-array studies
using chromosome panels unequivocally revealed γ-
H2AX bound to telomeric and subtelomeric sequences
[5], other non-telomeric genomic sequences may not
bind sufficient γ-H2AX to allow detection, leading to
underestimation of non-telomeric γ-H2AX.
In this study, we analyzed the location of sites of DNA
DSB damage along the chromosomes of mammalian cells
undergoing senescence in culture, using methodology
capable of rigorously distinguishing telomeric from non-
telomeric DNA damage. We demonstrated that senes-
cence-related γ-foci in human cells are mostly telomeric,
whereas foci in normal mouse cells are mostly non-telom-
eric. These results for the first time provide a quantitative
measure of the amounts of telomere-related and tel-
omere-independent DNA damage present in senescent
cells. The ability to distinguish between these two types of
γ-foci is also important in that it allows assessment of
whether each type of focus can be prevented or resolved.
As shown in Figures 3 and 4, the number of non-telomeric
DNA DSBs induced by reactive oxygen species was
decreased by culture in low oxygen, suggesting that this
type of DNA damage may be reversible. As the rate of
shortening of telomeric DNA can be slowed under condi-
tions of low oxygen [33], the accumulation of telomeric
damage may also be prevented or retarded, although res-
olution of telomeric damage, once formed, may require
the action of telomerase.
The presence of γ-foci has been detected on mitotic chro-
mosomes before and after anaphase, indicating check-
point adaptation, which has been described previously in
yeast cells, occurs in human cells [34-36]. Checkpoint
adaptation was originally described in yeast as the ability
to divide following a sustained checkpoint arrest in the
presence of unrepairable DNA breaks. Human osteosar-
coma cells also enter mitosis with γ-foci, suggesting that
Senescence in mammalian cells is associated with a set  number of γ-foci regardless of origin Figure 6
Senescence in mammalian cells is associated with a 
set number of γ-foci regardless of origin. (A) Numbers 
of γ-foci in the high population doublings or old cultures of 
the primary cell strains are arranged to show that the aver-
age total numbers of γ-foci per senescent or old cell are in 
the range 8–11, while the numbers of γ-foci found on the 
chromosome ends or on the arms are more variable. (B) The 
fractions of metaphase cells containing each range of γ-focal 
numbers are presented. Ranges of γ-focal numbers are taken 
to smooth the data.
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human cells are able to exit the checkpoint arrest and
divide before the damage has been fully repaired. In addi-
tion, the G2/M checkpoint seems to have a defined
threshold of 10 to 20 DSBs [37,38]. These findings
strongly support the hypothesis that mammalian cells can
enter into next cell cycle until DSBs accumulate to a
threshold level and senescence-related DNA damage sig-
nals (p53-p21 pathway and/or Rb-p16 pathway) are fully
activated to arrest the cell cycle.
It is unlikely that H2AX itself plays an essential role in
senescence induction, since H2AX-null mice appear to
have a similar lifespan to wild-type mice and maintain
intact cell-cycle checkpoints [39]. MEFs taken from H2AX-
null mice progress similarly toward senescence and senes-
cent H2AX-null MEF cells exhibit characteristics similar to
those from wild-type mice (data not shown). These find-
ings indicate that the lesions marked by γ-H2AX, rather
than γ-H2AX itself, are critical to the regulation of cellular
senescence.
In conclusion, our results reveal that cell populations at
the point of senescence appear to contain a relatively con-
stant number of γ-foci, irrespective of their relationship to
telomeres, and irrespective of whether the cells are of
human or mouse origin. Thus, the total number of γ-foci
at senescence appears to be independent of species or the
amount of stress. These results demonstrate that the sum-
mation of different types of DNA damage may induce in
vitro and in vivo aging.
Conclusion
Both telomeric and non-telomeric related DNA damage
responses are important determinants of mammalian cel-
lular senescence. The method used in this study to quan-
tify telomeric and non-telomeric DNA damages provides
a novel approach to elucidate the processes involved in
senescence and aging. The observations made in this
study also have significant implications for understanding
how aging changes cellular function and in designing
approaches for modifying the process of cellular senes-
cence.
Methods
Cell culture
WI-38 human lung fibroblasts and WI-38/SV40 (VA-13)
cell lines were obtained from Coriell Cell Repositories
(Camden, NJ, US) and BJ foreskin fibroblasts were
obtained from ATCC (Rockville, MD, US). Human fibrob-
lasts were grown in minimum essential medium contain-
ing 15% fetal bovine serum. TERT-null MEFs were
prepared from day 13.5 embryos. The whole embryo was
minced and dispersed in 0.25% trypsin and incubated for
5 minutes at 37°C. Cells were plated in T-75 flasks con-
taining Dulbecco's minimum essential medium plus 15%
fetal bovine serum. Splenocyte single cell suspensions
were isolated from mTR-null mice and cultured in RPMI
1640 medium containing 20% fetal bovine serum.
Splenic cells were stimulated for 48 hours using 5 μg/ml
ConA, 15 μg/ml LPS and 25 CU (Cetus Unit)/ml rIL-2.
Cells were maintained in a humidified incubator at 37°C,
5% CO2 and 20% or 3% O2. MEFs, grown to a pre-senes-
cent stage under normoxic (20% O2) conditions were
transferred to an atmosphere of 3% O2 and cultured to the
penultimate PD, which took about 2 weeks. WI-38 cells
and MEFs were incubated with 50 μM tempol for 48
hours. The 48-hour incubation time did not permit the
culture to go to the penultimate stage (see Additional file
1 for experimental detail).
PD times
WI-38 cells at 32–36 PDs, BJ cells at 35 PDs, MEFs at 3
PDs and TERT-null MEFs at 1 PD were used as low PDs.
WI-38 cells at 57 PDs, BJ cells at 70–72 PDs, MEFs at 7–9
PDs and TERT-null MEFs at 9 PDs were used as high PDs
[19,30,40] (see Additional file 1 for experimental detail).
First generation mTR-null mice at 2 months of age and
fifth generation mTR-null mice at 1 month were used as
young mice. First generation mTR-null mice at 15 months
and fifth generation mTR-null mice at 14 months were
used as old mice.
Mice
TERT-deficient mice and mTR-deficient mice were derived
as previously described [28,29]. Deficient mice were
maintained as heterozygotes on a Mus musculus domesticus
C57BL/6(B6) background. B6 mice were originally
obtained from the Frederick Cancer Research Center (Fre-
derick, MD, US). All procedures were approved by the
National Institute on Aging Animal Care and Use Com-
mittee and were in compliance with National Institutes of
Health guidelines.
Transduction of hTERT into WI-38 fibroblasts
Retroviral transduction of hTERT  into WI-38 was per-
formed as previously described [41,42]. Telomerase activ-
ity was detected in the hTERT-transduced WI-38, but not
in control cells with the vector alone, by polymerase chain
reaction-based telomere repeat amplification protocol
assay. Elongated telomeres in the hTERT-transduced WI-
38 were confirmed by Southern blot as previously
described [41].
Immunocytochemistry and FISH
Metaphase spreads were prepared as described previously
[20]. Slides were stained with mouse monoclonal anti-γ-
H2AX antibody (1/400 dilution, Upstate Biotechnology,
Inc., Lake Placid, NY, US) followed by Alexa-488-conju-
gated anti-mouse immunoglobulin G (1/400 dilution,
Molecular Probes, Eugene, OR, US). Then, the γ-H2AXEpigenetics & Chromatin 2008, 1:6 http://www.epigeneticsandchromatin.com/content/1/1/6
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stained cells were fixed with 50 mM ethylene glycol-bis
(succinic acid N-hydroxy-succinimide ester) (Sigma, St
Louis, MO, US) following telomere probe hybridization
according to the telomere FISH kit (DakoCytomation,
Glostrup, Denmark) protocol. DAPI (4,6-diamidino-2-
phenylindole-dihydrochroride) was used for visualiza-
tion of DNA. Signal was detected with an Olympus fluo-
rescent microscope (Olympus America Inc. Melville, NY,
US).
Western blot analysis
MEFs were lysed in lysis buffer (150 mM NaCl, 20 mM
hepes-NaOH (pH 7.4), 25% glycerol, 0.1 mM ethylenedi-
aminetetraacetic acid, 0.2% NP-40, 10 mM NaF) includ-
ing complete protease inhibitor (Roche, Indianapolis, IN,
US). The isolated proteins were boiled in sodium dodecyl
sulfate sample buffer and loaded on to 4% to 20% tris-gly-
cine pre-cast gels (Invitrogen, Carlsbad, CA, US) The sep-
arated proteins were transferred to a polyvinylidene
difluoride membrane (Invitrogen, Carlsbad, CA, US). For
immunoblotting, the membranes were incubated with
antibodies for p16 (1/200 dilution, Santa Cruz Biotech-
nology, Santa Cruz, CA, US), p21 (1/50 dilution, Abcam,
Cambridge, UK), p53 (1/2000 dilution, Cell Signaling
Technology, Danvers, MA, US), phospho-Ser15-p53 (1/
1000 dilution, Cell Signaling Technology, Danvers, MA,
US) and β-actin (1/1000 dilution, Abcam, Cambridge,
UK). The blots were incubated with horseradish peroxi-
dase-conjugated anti-mouse or anti-rabbit antibody (1/
10,000 dilution, Amersham Bioscience, Piscataway, NJ,
US). The blots were visualized by enhanced chemilumi-
nescence Western blotting detection reagents (Amersham
Bioscience, Piscataway, NJ, US).
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Additional material
Additional file 1
Experimental design. WI-38 cells and mouse embryonic fibroblasts 
(MEFs) were treated with 100 ng/ml colcemid for 3 hours, and then 
taken for metaphase spreads. Red arrows show time points at which met-
aphase spreads were obtained. (A, top time line) WI-38 cells at 32 to 36 
population doublings (PDs) (low PDs). WI-38 cells at 57 PDs (high 
PDs). (A, middle time line) WI-38 cells at 50 PDs cultured in 50 μM 
tempol for 48 hours (OX). (A, bottom time line) hTERT-transduced WI-
38 cells were cultured more than 20 PDs (TERT). hTERT transduction 
was performed into WI-38 cells at 55 PDs. (B, top time line) MEFs at 
three PDs (low PDs). MEFs at seven PDs (high PDs 20%). (B, middle 
time line) MEFs cultured in 20% O2, shifted at seven PDs to 3% O2 and 
cultured to nine PDs (high PDs 3%). (B, bottom time line) MEFs at 
seven PDs cultured in 50 μM tempol for 48 hours (OX).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
8935-1-6-S1.pdf]
Additional file 2
Amount of SA-β-gal positive cells (%) and the effect of colcemid treat-
ment on γ-foci formation. Cells were fixed at the indicated population 
doublings (PDs) and SA-β-gal staining was performed following the man-
ufacturer's instructions (Cell Signaling Technology, Danvers, MA, US). 
(A) Amount of SA-β-gal positive cells in WI-38 or BJ cells. (B) Amount 
of SA-β-gal positive cells in mouse embryonic fibroblasts (MEFs). (C) 
Distribution of γ-foci on metaphases of WI-38. WI-38 at 46 PDs treated 
with/without 100 ng/ml colcemid for 3 hours, and then taken for met-
aphase spreads. Proportion (%) of each type of damage is shown in each 
graph bar. Scoring is as in Figure 1B. On average more than 10 met-
aphases were screened per point in independent experiments. Error bars 
signify standard errors.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
8935-1-6-S2.pdf]
Additional file 3
Experimental design of oxygen transfer experiments shown in Figure 3D. 
Mouse embryonic fibroblasts (MEFs) at three population doublings were 
cultured in 20% O2 or 3% O2 for 5 days and transferred to 3% O2 or 20% 
O2, respectively. Each day after transfer, MEFs were fixed and immunos-
tained with the γ-H2AX antibody.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
8935-1-6-S3.pdf]
Additional file 4
Distribution of senescence-related γ-foci in high population doublings of 
WI-38 cells and in VA-13 with alternative lengthening of telomeres. Scor-
ing of γ-foci as along the chromatid arms proximal to the telomere, along 
the chromatid arms distal to the telomeres, on the chromatid ends with 
fluorescence in situ hybridization (FISH) signal or on the chromatid ends 
without FISH signal.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
8935-1-6-S4.pdf]Epigenetics & Chromatin 2008, 1:6 http://www.epigeneticsandchromatin.com/content/1/1/6
Page 12 of 12
(page number not for citation purposes)
Acknowledgements
We are grateful to J Carl Barrett for useful discussions. We thank Jennifer 
Dickey for critical reading of this manuscript, Christophe Redon, Mykyta 
Sokolov and other members of the Laboratory of Molecular Pharmacology 
for help in this work. This work was supported in part by the Intramural 
Research Program of the National Cancer Institute, CCR, National Insti-
tutes of Health. AJN was supported by the JSPS Research Fellowship for 
Japanese Biomedical and Behavioral Researchers at the National Institutes 
of Health.
References
1. Hayflick L, Moorhead PS: The serial cultivation of human diploid
cell strains.  Exp Cell Res 1961, 25:585-621.
2. Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad
things happen to good cells.  Nat Rev Mol Cell Biol 2007, 8:729-740.
3. Blasco MA: Telomeres and human disease: Ageing, cancer
and beyond.  Nat Rev Genet 2005, 6:611-622.
4. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt
FW:  DNA repair, genome stability, and aging.  Cell 2005,
120:497-512.
5. D'Adda Di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P,
Von Zglinicki T, Saretzki G, Carter NP, Jackson SP: A DNA damage
checkpoint response in telomere-initiated senescence.
Nature 2003, 426:194-198.
6. Bakkenist CJ, Drissi R, Wu J, Kastan MB, Dome JS: Disappearance
of the telomere dysfunction-induced stress response in fully
senescent cells.  Cancer Res 2004, 64:3748-3752.
7. Herbig U, Jobling WA, Chen BPC, Chen DJ, Sedivy JM: Telomere
shortening triggers senescence of human cells through a
pathway involving ATM, p53, and p21CIP1, but not
p16INK4a.  Mol Cell 2004, 14:501-513.
8. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner
WM, Barrett JC: Senescing human cells and ageing mice accu-
mulate DNA lesions with unrepairable double-strand
breaks.  Nat Cell Biol 2004, 6:168-170.
9. Sedelnikova OA, Horikawa I, Redon C, Nakamura A, Zimonjic DB,
Popescu NC, Bonner WM: Delayed kinetics of DNA double-
strand break processing in normal and pathological aging.
Aging Cell 2008, 7:89-100.
10. Harley CB, Futcher AB, Greider CW: Telomeres shorten during
ageing of human fibroblasts.  Nature 1990, 345:458-460.
11. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM: DNA dou-
ble-stranded breaks induce histone H2AX phosphorylation
on serine 139.  J Biol Chem 1998, 273:5858-5868.
12. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bon-
ner WM: A critical role for histone H2AX in recruitment of
repair factors to nuclear foci after DNA damage.  Curr Biol
2000, 10:886-895.
13. Takai H, Smogorzewska A, De Lange T: DNA damage foci at dys-
functional telomeres.  Curr Biol 2003, 13:1549-1556.
14. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM: Cellular senes-
cence in aging primates.  Science 2006, 311:1257.
15. Horikawa IY, T Barrett JC: Cellular senescence mechanisms
independent of telomere shortening and telomerase: other
barriers to cell immortalization and carcinogenesis.  J Anti
Aging Med 2000, 3:373-382.
16. Itahana K, Campisi J, Dimri GP: Mechanisms of cellular senes-
cence in human and mouse cells.  Biogerontology 2004, 5:1-10.
17. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C,
Schurra C, Garre M, Giovanni Nuciforo P, Bensimon A, Maestro R,
Pelicci PG, d'Adda di Fagagna F: Oncogene-induced senescence is
a DNA damage response triggered by DNA hyper-replica-
tion.  Nature 2006, 444:638-642.
18. Wright WE, Shay JW: Telomere dynamics in cancer progres-
sion and prevention: Fundamental differences in human and
mouse telomere biology.  Nat Med 2000, 6:849-851.
19. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J:
Oxygen sensitivity severely limits the replicative lifespan of
murine fibroblasts.  Nat Cell Biol 2003, 5:741-747.
20. Nakamura A, Sedelnikova OA, Redon C, Pilch DR, Sinogeeva NI,
Shroff R, Lichten M, Bonner WM: Techniques for γ-H2AX detec-
tion.  Methods Enzymol 2006, 409:236-250.
21. Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJL, Van
Lohuizen M, Band V, Campisi J, Dimri GP: Control of the replica-
tive life span of human fibroblasts by p16 and the polycomb
protein Bmi-1.  Mol Cell Biol 2003, 23:389-401.
22. Von Zglinicki T, Saretzki G, Ladhoff J, Fagagna FDD, Jackson SP:
Human cell senescence as a DNA damage response.  Mech
Ageing Dev 2005, 126:111-117.
23. Ksiazek K, Passos JF, Olijslagers S, Saretzki G, Martin-Ruiz C, von
Zglinicki T: Premature senescence of mesothelial cells is asso-
ciated with non-telomeric DNA damage.  Biochem Biophys Res
Commun 2007, 362:707-711.
24. Prowse KR, Greider CW: Developmental and tissue-specific
regulation of mouse telomerase and telomere length.  Proc
Natl Acad Sci USA 1995, 92:4818-4822.
25. Reddel RR: Alternative lengthening of telomeres, telomerase,
and cancer.  Cancer Lett 2003, 194:155-162.
26. Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC,
Hahn SM, Russo A: A low molecular weight antioxidant
decreases weight and lowers tumor incidence.  Free Radic Biol
Med 2003, 34:93-102.
27. Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB,
Wynshaw-Boris A: Cancer chemoprevention by the antioxi-
dant tempol acts partially via the p53 tumor suppressor.
Hum Mol Genet 2005, 14:1699-1708.
28. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho
RA, Greider CW: Telomere shortening and tumor formation
by mouse cells lacking telomerase RNA.  Cell 1997, 91:25-34.
29. Chiang YJ, Hemann MT, Hathcock KS, Tessarollo L, Feigenbaum L,
Hahn WC, Hodes RJ: Expression of telomerase RNA template,
but not telomerase reverse transcriptase, is limiting for tel-
omere length maintenance in vivo.  Mol Cell Biol 2004,
24:7024-7031.
30. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P,
Campisi J: Reversal of human cellular senescence: roles of the
p53 and p16 pathways.  EMBO J 2003, 22:4212-4222.
31. Ben-Porath I, Weinberg RA: When cells get stressed: an integra-
tive view of cellular senescence.  J Clin Invest 2004, 113:8-13.
32. Gartel AL, Tyner AL: Transcriptional regulation of the
p21((WAF1/CIP1)) gene.  Exp Cell Res 1999, 246:280-289.
33. Von Zglinicki T: Oxidative stress shortens telomeres.  Trends
Biochem Sci 2002, 27:339-344.
34. Sandell LL, Zakian VA: Loss of a yeast telomere: arrest, recov-
ery, and chromosome loss.  Cell 1993, 75:729-739.
35. Rogakou EP, Boon C, Redon C, Bonner WM: Megabase chromatin
domains involved in DNA double-strand breaks in vivo.  J Cell
Biol 1999, 146:905-916.
36. Syljuasen RG, Jensen S, Bartek J, Lukas J: Adaptation to the ioniz-
ing radiation-induced G2 checkpoint occurs in human cells
and depends on checkpoint kinase 1 and Polo-like kinase 1
kinases.  Cancer Res 2006, 66:10253-10257.
37. Deckbar D, Birraux J, Krempler A, Tchouandong L, Beucher A,
Walker S, Stiff T, Jeggo P, Lobrich M: Chromosome breakage
after G2 checkpoint release.  J Cell Biol 2007, 176:749-755.
38. Lobrich M, Jeggo PA: The impact of a negligent G2/M check-
point on genomic instability and cancer induction.  Nat Rev
Cancer 2007, 7:861-869.
39. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen
HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E,
Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-
Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenz-
weig MC, Nussenzweig A: Genomic instability in mice lacking
histone H2AX.  Science 2002, 296:922-927.
40. Kortlever RM, Higgins PJ, Bernards R: Plasminogen activator
inhibitor-1 is a critical downstream target of p53 in the
induction of replicative senescence.  Nat Cell Biol 2006,
8:877-884.
41. Carney SA, Tahara H, Swartz CD, Risinger JI, He H, Moore AB, Hase-
man JK, Barrett JC, Dixon D: Immortalization of human uterine
leiomyoma and myometrial cell lines after induction of tel-
omerase activity: molecular and phenotypic characteristics.
Lab Invest 2002, 82:719-728.
42. Forsyth NR, Evans AP, Shay JW, Wright WE: Developmental dif-
ferences in the immortalization of lung fibroblasts by telom-
erase.  Aging Cell 2003, 2:235-243.